Option chain shows key data for Marker Therapeutics's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Marker Therapeutics.

Marker Therapeutics (NASDAQ:MRKR) Stock, Option Chain

Marker Therapeutics

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and innovative peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets. It is also developing peptide-based immunotherapeutic vaccines for the treatment of metastatic solid tumors, as well as PolyStart.

Biotech

News

Health Care

General

MRKR

Marker Therapeutics Inc (NASDAQ: MRKR) announced it is restructuring its clinical programs and strategic prioritization of its multi-tumor associated antigen (multiTAA)-specific T cell product pipeline. 

Cancer Cell Therapy Focused Marker Therapeutics Announces Pipeline Prioritization

Movers

Marker Therapeutics Inc (NASDAQ: MRKR) released the preliminary results of the first participant treated with MT-601, its multi-tumor associated antigen (multiTAA)-specific T cell product targeting 6 TAAs, in the Phase 1 multicenter 

Why Is Blood Cancer Focused Marker Therapeutics Stock Trading Higher Today?

Penny Stocks

Small Cap

Intraday Update

Markets

Trading Ideas

AAMC

AVTA

AXLA

BFLY

BGLC

BGNE

BOWL

CING

CRNX

CXAI

ELUT

FLWS

GRNT

HKIT

IMPL

KXIN

LPTV

MGTA

MULN

NEPT

NUWE

PODC

PSTV

PUYI

SGMA

SMRT

SPCE

SWIN

TNON

TSLA

Hostess Brands, Inc. - Class A Common Stock

TWNK

VIRC

WLGS

YOSH

Gainers


	Crinetics Pharmaceuticals, Inc.  (NASDAQ: CRNX) jumped 76% to $28.13 after the company&#39;s once-daily oral paltusotine achieved the primary and secondary endpoints in the Phase 3 PATHFNDR-1 study in acromegaly.


Why Avantax Shares Are Trading Higher By Over 27%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

Marker Therapeutics Inc

Boston Scientific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSX#NYSE">BSX</a>) has outperformed the market over the past 10 years by 8.74% on an annualized basis producing an average annual return of 19.64%. Currently, Boston Scientific has a market capitalization of $148.32 billion. 
Buying $1000 In BSX: If an investor had bought $1000 of BSX stock 10 years ago, it would be worth $5,903.87 today based on a price of $100.50 for BSX at the time of writing.
<h3>Boston Scientific's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740522627_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In Boston Scientific 10 Years Ago Would Be Worth This Much Today

Stabilis Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLNG#NASDAQ">SLNG</a>) reported quarterly earnings of $0.12 per share. This is a 50 percent increase over earnings of $0.08 per share from the same period last year. The company reported quarterly sales of $17.30 million. This is a 4.16 percent decrease from sales of $18.05 million same period last year.

Earnings

Earnings Beats

Earnings Misses

SLNG

Stabilis Solutions Q4 EPS $0.12, increase over earnings of $0.08 during last year same period. Sales $17.30M decreased from sales of $18.05 during last year same period.

WIIM

SCCO

Shares of copper stocks are trading higher after President Trump reportedly ordered a new tariff probe into US copper imports.

Axon Enterprise Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXON#NASDAQ">AXON</a>) reported its fourth-quarter results after Tuesday's closing bell. Here's a look at the <a href="https://www.benzinga.com/pressreleases/25/02/n43956202/axon-2024-revenue-grows-33-to-2-1-billion-third-consecutive-year-of-30-annual-growth">details from the report. </a>
The Details: Axon Enterprise reported quarterly earnings of $2.08 per share, which beat the analyst consensus estimate of $1.40. Quarterly revenue clocked in at $575 million, which beat the analyst consensus estimate of $566.08 million and is an increase over revenue of $432.14 million from the same period last year.
For fiscal 2024 Axon reported: 
<ul>
<li>Axon Cloud &amp; Services revenue grew 44% to $806 million</li>
<li>Annual recurring revenue grew 37% to $1 billion</li>
<li>Annual net income of $377 million supported non-GAAP net income of $466 million</li>
</ul>
Read Next:<a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/02/43949800/tesla-competes-against-chinese-rivals-with-one-hand-tied-behind-its-back-analyst"> Tesla Competes Against Chinese Rivals &#8216;With One Hand Tied Behind Its Back&#8217;: Analyst</a>
&#8220;We closed 2024 with record quarterly revenue of $575 million in Q4, up 34% year over year, for our 12th consecutive quarter of 25%+ growth. TASER revenue of $221 million grew 37% year over year, fueled by the continued scaling of TASER 10 and growing adoption of our VR training solutions,&#8221; the company wrote in a letter to shareholders. 
&#8220;Sensors &amp; Other revenue of $124 million grew 18% year over year, supported by continued strong demand for Axon Body 4 and Axon Fleet 3. Axon Cloud &amp; Services accounted for 40% of our total revenue, growing 41% year over year to $230 million as adoption of our premium subscription offerings continued to build,&#8221; the company said. 
Outlook: Axon Enterprise sees fiscal 2025 revenue in a range of $2.55 billion to $2.65 billion, versus the $2.55 billion estimate. 
AXON Price Action: According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Axon Enterprise shares are up 12.75% after hours at $559.99 Tuesday.  
Read Next:<a href="https://www.benzinga.com/government/regulations/25/02/43903335/financial-crime-weekly-1-4-billion-ethereum-stolen-in-largest-crypto-hack-ever-sec-creates-cyber-and-emerging-technologies-unit">&nbsp;</a>
<ul>
<li><a href="https://www.benzinga.com/general/market-summary/25/02/43951080/bitcoin-plunges-as-consumer-confidence-falls-whats-driving-markets-tuesday">Bitcoin Plunges As Consumer Confidence Falls: What&#8217;s Driving Markets Tuesday?</a></li>
</ul>
Image courtesy of Axon Enterprise, Inc.

After-Hours Center

Tech

AXON

Axon Enterprise Shares Rally After Better-Than-Expected Q4 Results, Strong Forward Guidance

<a href="https://www.reuters.com/world/us/trump-orders-new-tariff-probe-into-us-copper-imports-2025-02-25/" title="https://www.reuters.com/world/us/trump-orders-new-tariff-probe-into-us-copper-imports-2025-02-25/">https://www.reuters.com/world/us/trump-orders-new-tariff-probe-into-us-copper-imports-2025-02-25/</a>

Macro Economic Events

Economics

'Trump Orders New Tariff Probe Into U.S. Copper Imports; U.S. Commerce Secretary Lutnick Says Will Investigate Possible Imposition Of Tariffs To Rebuild U.S. Copper Industry, Says "No Exemptions, No Exceptions; It's Time For Copper To Come Home"; White House Official Says President Trump Will Recognize Copper Sector As National Security Issue, Commerce Dept Will Investigate Under Section 232' - Reuters News

SMCI

Super Micro Computer shares are trading higher after the company filed its quarterly report.

Effective February 19, 2025, Stephanie F. Pope no longer held the title of Chief Operating Officer of The Boeing Company (the "Company"). Ms. Pope continues to serve as Executive Vice President; President and Chief Executive Officer, Boeing Commercial Airplanes.On February 19, 2025, Sabrina Soussan and the Board of Directors of the Company decided that Ms. Soussan would not stand for re-election at the Company's 2025 Annual Meeting of Shareholders. The decision was not due to any disagreement with the Company on any matter relating to its operations, policies or practices. In connection with this decision, the Board approved a reduction in its size, effective as of the 2025 Annual Meeting of Shareholders.

Management

Boeing's Stephanie Pope Steps Down As COO, Continues As EVP And CEO Of Commercial Airplanes; Sabrina Soussan To Exit Board In 2025, Board Size To Reduce

Super Micro Computer Q2 2025 Revenue $5.678B Vs $3.665B YoY

Super Micro Computer Q2 2025 Diluted EPS $0.51 Vs $0.51 YoY

Super Micro Computer Q2 2025 EPS $0.54 Vs $0.55 YoY

Luxfer Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LXFR#NYSE">LXFR</a>) is looking for FY2025 Adj EPS of $0.95-$1.05 vs $1.05 analyst estimate..

Guidance

LXFR

Luxfer Holdings Sees FY2025 Adj EPS $0.95-$1.05 vs $1.05 Est

Luxfer Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LXFR#NYSE">LXFR</a>) reported quarterly earnings of $0.29 per share which beat the analyst consensus estimate of $0.22 by 31.82 percent. This is a 222.22 percent increase over earnings of $0.09 per share from the same period last year. The company reported quarterly sales of $103.40 million which beat the analyst consensus estimate of $89.50 million by 15.53 percent. This is a 7.82 percent increase over sales of $95.90 million the same period last year.

Luxfer Holdings Q4 Adj $0.29 Beats $0.22 Estimate, Sales $103.40M Beat $89.50M Estimate

Super Micro Computer Reports Cash, Cash Equivalents As Of Dec. 31, 2024 $1.43B

First Solar, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NASDAQ">FSLR</a>) reported its fourth-quarter results after Tuesday's closing bell. Here's a look at the <a href="https://www.benzinga.com/pressreleases/25/02/b43956517/first-solar-inc-announces-fourth-quarter-and-full-year-2024-financial-results-and-2025-guidance">details from the report. </a>
The Details: First Solar reported quarterly earnings of $3.65 per share, which missed the analyst consensus estimate of $4.71. Quarterly revenue clocked in at $1.51 billion, which beat the analyst consensus estimate of $1.46 billion and is an increase over revenue of $1.15 billion from the same period last year.
The company reported 2024 net bookings of 4.4 GW with an average selling price of 30.5 cents per watt and ended 2024 with a net cash balance of $1.2 billion.
Read Next:<a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/02/43949800/tesla-competes-against-chinese-rivals-with-one-hand-tied-behind-its-back-analyst"> Tesla Competes Against Chinese Rivals &#8216;With One Hand Tied Behind Its Back&#8217;: Analyst</a>
First Solar <a href="https://www.benzinga.com/pressreleases/25/02/b43956195/first-solar-initiates-legal-action-against-jinkosolar-for-infringement-of-topcon-technology-patent">also announced </a>it initiated legal action against JinkoSolar, alleging infringement of TOPCon technology patents. 
&#8220;In 2024, we continued building the foundations required for our long-term growth strategy,&#8221; said Mark Widmar, CEO of First Solar. 
&#8220;Even as we maintained a highly selective approach to bookings, we expanded manufacturing capacity by commissioning our Alabama facility and progressed construction of our new Louisiana facility, established the infrastructure we anticipate will accelerate innovation with a new R&amp;D center in Ohio, and produced and shipped a historic volume of modules,&#8221; Widmar added. 
Outlook: The company issued the following fiscal 2025 guidance: 
<ul>
<li>2025 net sales guidance of $5.3 billion to $5.8 billion</li>
<li>2025 earnings per diluted share guidance of $17 to $20</li>
<li>2025 year-end net cash balance guidance of $0.7 billion to $1.2 billion</li>
</ul>
FSLR Price Action: According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, First Solar shares are up 1.73% after hours at $151.01 Tuesday.  
Read Next:<a href="https://www.benzinga.com/government/regulations/25/02/43903335/financial-crime-weekly-1-4-billion-ethereum-stolen-in-largest-crypto-hack-ever-sec-creates-cyber-and-emerging-technologies-unit">&nbsp;</a>
<ul>
<li><a href="https://www.benzinga.com/general/market-summary/25/02/43951080/bitcoin-plunges-as-consumer-confidence-falls-whats-driving-markets-tuesday">Bitcoin Plunges As Consumer Confidence Falls: What&#8217;s Driving Markets Tuesday?</a></li>
</ul>
Image: Shutterstock

FSLR

First Solar Reports Mixed Q4 Results: EPS Miss, Revenues Beat, FY Net Bookings Of 4.4 Gigawatts

Ginkgo Bioworks Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DNA#NYSE">DNA</a>) sees FY2025 sales of $160.000 million-$180.000 million vs $203.80 million analyst estimate.

Ginkgo Bioworks Holdings Sees FY2025 Sales $160.000M-$180.000M vs $203.80M Est

Ginkgo Bioworks Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DNA#NYSE">DNA</a>) reported quarterly losses of $(2.00) per share which missed the analyst consensus estimate of $(1.77) by 12.99 percent. This is a 53.27 percent increase over losses of $(4.28) per share from the same period last year. The company reported quarterly sales of $43.85 million which missed the analyst consensus estimate of $44.46 million by 1.39 percent. This is a 26.16 percent increase over sales of $34.76 million the same period last year.

Ginkgo Bioworks Holdings Q4 EPS $(2.00) Misses $(1.77) Estimate, Sales $43.85M Miss $44.46M Estimate

A new Benzinga poll asks readers if the newly unveiled Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) iPhone 16e is too expensive to be a budget option or could be a value, ahead of <a href="https://www.benzinga.com/tech/25/02/43820197/apple-unveils-iphone-16e-with-a18-chip-ai-features-599-price-tag">the phone's release.</a>
 What Happened: Apple recently<a href="https://www.benzinga.com/markets/25/02/43840286/apples-iphone-16e-to-drive-revenue-growth-for-tim-cooks-company-says-top-analyst"> unveiled the iPhone 16e </a>smartphone, which comes with a lower starting price than the iPhone 16 and has many of the features Apple fans have come to know and love.
The phone replaces the iPhone SE budget model launched in 2022. The new phone comes in five color options, has storage options of 128 GB to 512 GB, has the Apple A18 chip and comes with Apple Intelligence AI features.
Preorders for the iPhone 16e began on Feb. 21, and the phone will officially go on sale on Feb. 28. The phone starts at $599, and the iPhone 16 starts at $799.
Benzinga recently asked readers about the potential value of the phone.
"Do you think the $599 starting price for Apple's new ‘budget' iPhone 16e is…?" Benzinga asked.
These were the results:
<ul>
<li>Too expensive for a budget option: 34%</li>
<li>Reasonably priced: 25%</li>
<li>Overpriced regardless of category: 22%</li>
<li>A great value for an iPhone: 18%</li>
</ul>
The top vote getter in the poll was the new iPhone 16e being too expensive to be considered a budget option. The phone being a great value for an iPhone ranked last in the poll.
Read Also: <a href="https://www.benzinga.com/general/entertainment/25/02/43855319/apple-stock-set-for-streaming-lift-severance-breaks-record-after-x-ads-tim-cook-promo">Apple Stock Set For Streaming Lift? &#8216;Severance&#8217; Breaks Record After X Ads, Tim Cook Promo</a>
Why It's Important: While the poll suggests potential bad news for Apple, with readers believing the new iPhone is too expensive as a budget option, the phone&#8217;s reasonable price was the second highest vote-getter at 25%.
This suggests that the phone could have a target audience and be a strong seller for the technology giant.
Deepwater Management's Gene Munster recently predicted Apple could get a revenue boost from the new lower-priced smartphone.
Munster highlighted that the iPhone 16e was the most affordable Apple phone that supports Apple Intelligence. The tech investor also predicts the iPhone 16e could make up 10% of Apple's revenue, higher than the 7% the company previously got from the iPhone SE.
The new iPhone is also the first iPhone to feature Apple's own cellular modem chip, which could help the company break away from a supplier and test the product ahead of the future iPhone 17 launch.
AAPL Price Action: Apple stock is up 0.1% to $247.35 on Tuesday versus a 52-week trading range of $164.08 to $260.08. Apple stock is up 1.9% year-to-date in 2025 and up 37% over the last year.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/25/02/43827658/exclusive-apple-nvidia-tesla-or-boeing-which-company-faces-the-biggest-risk-from-trumps-china-tariffs-35-say-this-stock">EXCLUSIVE: Apple, Nvidia, Tesla Or Boeing? Which Company Faces the Biggest Risk From Trump&#8217;s China Tariffs — 35% Say This Stock</a></li>
</ul>
The study was conducted by Benzinga from Feb. 19, 2025 through Feb. 21, 2025. It included the responses of a diverse population of adults 18 or older. Opting into the survey was completely voluntary, with no incentives offered to potential respondents. The study reflects results from 134 adults.
Photo: Shutterstock

Exclusives

AAPL

EXCLUSIVE: Apple iPhone 16e – A Smart Buy Or Overpriced? Here's What 34% Think

Intuit Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTU#NASDAQ">INTU</a>) reported fiscal second-quarter financial results Tuesday after the bell. Here&#8217;s a look at the key details <a href="https://www.benzinga.com/pressreleases/25/02/b43956126/intuit-reports-strong-second-quarter-results-and-reiterates-full-year-guidance">from the quarter</a>.
<ul>
<li>Q2 Revenue: $4 billion, versus <a href="https://www.benzinga.com/calendars/earnings">estimates</a> of $3.83 billion</li>
</ul>
<ul>
<li>Q2 Adjusted EPS: $3.32, versus estimates of $2.58</li>
</ul>
Total revenue was up 17% year-over-year. Global Business Solutions revenue was up 19% year-over-year and Online Ecosystem revenue increased 21% year-over-year. Credit Karma revenue jumped 36% year-over-year and Consumer Group revenue increased 3%, while ProTax Group revenue fell 1% year-over-year. 
Intuit reported second-quarter operating income of $593 million, and adjusted operating income of $1.3 billion, up 26% year-over-year. The company ended the quarter with $2.5 billion in total cash and investments and $6.3 billion in debt.
&#8220;We are making great progress fueling the financial success of consumers, businesses, and accountants with our AI-driven expert platform,&#8221; said Sasan Goodarzi, CEO of Intuit.
&#8220;Intuit Assist is delivering &#8216;done-for-you&#8217; experiences to complete tasks, automate end-to-end workflows, and connect customers to AI-powered human experts, powering their prosperity.&#8221;
Check This Out: <a href="https://www.benzinga.com/news/earnings/25/02/43957497/lucid-q4-earnings-revenue-beat-eps-beat-20k-production-guidance-for-2025-ceo-transition-and-more">Lucid Q4 Earnings: Revenue Beat, EPS Beat, 20K Production Guidance For 2025, CEO Transition And More</a>
Outlook: Intuit expects third-quarter revenue of $7.55 billion to $7.6 billion. The company sees third-quarter adjusted earnings in the range of $10.89 to $10.95 per share. 
Intuit expects full-year 2025 revenue to be between $18.16 billion and $18.35 billion versus estimates of $20.53 billion, according to estimates of <a href="http://pro.benzinga.com">Benzinga Pro</a>. The company anticipates full-year earnings of $19.16 to $19.36 per share versus estimates of $22.13 per share. 
&#8220;We are confident in delivering double-digit revenue growth and expanding margin this year, and we are reiterating our full year&nbsp;guidance&nbsp;for fiscal 2025,&#8221; said Sandeep Aujla, CFO of Intuit.
Intuit executives are currently discussing the quarter on a conference call that started at 4:30 p.m. ET.
INTU Price Action: <a href="https://www.benzinga.com/quote/INTU" target="_blank" rel="noreferrer noopener">Intuit shares</a> were up 6.12% after hours, trading at $589.64 at the time of publication Tuesday, according to <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Photo: Shutterstock.

INTU

Intuit Shares Rise Following Q2 Earnings Beat: The Details

Tetra Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TTI#NYSE">TTI</a>) reported quarterly earnings of $0.03 per share which met the analyst consensus estimate. This is unchanged from the same period last year. The company reported quarterly sales of $134.50 million which missed the analyst consensus estimate of $138.21 million by 2.68 percent. This is a 12.16 percent decrease over sales of $153.13 million the same period last year.

Tetra Technologies Q4 Adj $0.03, Inline, Sales $134.50M Miss $138.21M Estimate

Providing a diverse range of perspectives from bullish to bearish, 4 analysts have published ratings on Topgolf Callaway Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MODG#NYSE">MODG</a>) in the last three months.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $11.25, a high estimate of $13.00, and a low estimate of $9.00. This current average has decreased by 13.46% from the previous average price target of $13.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1740520863_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
The analysis of recent analyst actions sheds light on the perception of Topgolf Callaway Brands by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>George Kelly</td>
<td>Roth MKM</td>
<td>Lowers</td>
<td>Buy</td>
<td>$11.00</td>
<td>$16.00</td>
</tr>
<tr>
<td>Matthew Boss</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$9.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>Michael Swartz</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$12.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Randal Konik</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$13.00</td>
<td>$11.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Topgolf Callaway Brands. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Topgolf Callaway Brands compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Topgolf Callaway Brands's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Topgolf Callaway Brands's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/MODG/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Topgolf Callaway Brands analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>About Topgolf Callaway Brands</h2>
Topgolf Callaway Brands Corp is a modern golf and active lifestyle company that provides world-class golf entertainment experiences, designs and manufactures premium golf equipment, and sells golf and active lifestyle apparel and other accessories through brands such as, Topgolf, Callaway Golf, Odyssey, TravisMathew, Jack Wolfskin, OGIO and Toptracer. The company's reportable segments are; Topgolf, Golf Equipment and Active Lifestyle. Majority of the revenue is generated from its Topgolf segment which is predominantly comprised of service revenues and expenses from the company operated Topgolf venues, Toptracer ball-flight tracking technology, and WGT digital golf game. Geographically, majority of the revenue for the company is derived from United States.
<h3>Unraveling the Financial Story of Topgolf Callaway Brands</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Revenue Challenges: Topgolf Callaway Brands's revenue growth over 3 months faced difficulties. As of 30 September, 2024, the company experienced a decline of approximately -2.66%. This indicates a decrease in top-line earnings. When compared to others in the Consumer Discretionary sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Topgolf Callaway Brands's net margin is impressive, surpassing industry averages. With a net margin of -0.36%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of -0.09%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Topgolf Callaway Brands's ROA stands out, surpassing industry averages. With an impressive ROA of -0.04%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Topgolf Callaway Brands's debt-to-equity ratio surpasses industry norms, standing at 0.76. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>What Are Analyst Ratings?</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

MODG

What Analysts Are Saying About Topgolf Callaway Brands Stock

Press Releases

Marker Therapeutics Awarded $2 Million Grant from NIH in Support of Phase 1 Study Investigating MT-601 in CAR-Relapsed Patients with Non-Hodgkin's Lymphoma

Marker Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates

Korro Announces Addition of Industry Veteran Katharine Knobil to and Resignation of David Lucchino From Its Board of Directors

Marker Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates

Marker Therapeutics to Present at the Citizens JMP Hematology and Oncology Summit

Marker Therapeutics to Present at the 2024 Ladenburg Thalmann & Co. Virtual Oncology Innovators and Investors Symposium

Financing

Marker Therapeutics Awarded $9.5 Million Grant from the Cancer Prevention & Research Institute of Texas (CPRIT) to Support the Investigation of MT-601 in Patients with Pancreatic Cancer

Marker Therapeutics Provides a Clinical Update on MT-601 in Patients with Lymphoma

Marker Therapeutics Announces $16.1 Million Private Placement

Marker Therapeutics to Present at the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference

Comments

Marker Therapeutics

Marker Therapeutics (MRKR) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga